Vanessa Daniel

Vanessa Daniel joined DNDi in December 2022 as Alliance and Operations Leader.

Vanessa comes with two decades of experience in R&D, clinical trials, and pharmacovigilance (PV). She has co-authored national scientific guidelines, contributed on several national technical advisory committees and actively advocated alignment of pharmacovigilance regulations in Malaysia.

Prior to joining DNDi, Vanessa was the Deputy General Manager for Clinical Affairs & Pharmacovigilance at Pharmaniaga Berhad, the largest government-linked pharmaceutical company in Malaysia, where she was actively involved in the clinical development, pharmacovigilance and registration of generic drugs, biologics and NCEs including Ravida (ravidasvir) in multiple territories.